NCT00024531View on ClinicalTrials.gov

Lipitor as a Treatment for Alzheimer's Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

98

Participants

Timeline

Start Date

October 31, 2000

Study Completion Date

August 31, 2004

Conditions
Alzheimer Disease
Interventions
DRUG

Atorvastatin calcium

Trial Locations (1)

85351

Sun Health Research Institute, Sun City

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Institute for the Study of Aging (ISOA)

OTHER